Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

ambrisentan

ambrisentan
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Letairis TABLET, ORAL 5 mg, 10 mg    
Comments:

Non-Formulary.  Automatic interchange.

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

ambrisentan (Letairis)

  • 5 mg oral once daily
  • 10 mg oral once daily

macitentan(Opsumit)

  • 10 mg oral once daily
  • 10 mg oral once daily

 

The Ambrisentan REMS programs are no longer in effect as of April 2025.

Discharge Prescription Considerations

  • Ambrisentan is only available through specialty pharmacies.  For a New Start (male or female), HH Pharmacy may send the patient home with a max 15 day supply of drug.  Work closely with the prescribing physician and patient to determine when the specialty pharmacy will deliver first maintenance supply of drug.

 

 

Reviewed: September 23, 2008

Updated: May 2019 (REMS confirmation instructions), June 2020 (Interchange with Opsumit), May 2025 (REMS update)

Last updated: Dec. 24, 2025
Rhazdrugs ambrisentan






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved